Connor, Clark & Lunn Investment Management Ltd. Legend Biotech Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 7,324 shares of LEGN stock, worth $253,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,324
Previous 6,489
12.87%
Holding current value
$253,630
Previous $316,000
24.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
76.3MCall Options Held
199KPut Options Held
342K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$387 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$260 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$230 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$198 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$198 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.8B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...